到 2028 年南美洲和中美洲品牌仿制药市场预测 – COVID-19 影响和区域分析 – 按治疗应用(肿瘤学、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛药和抗炎药等) )、分销渠道(医院、零售药店、网上药店和药店)、药品类别(烷化剂、抗代谢药、激素、抗高血压药、降脂药、抗抑郁药、抗精神病药、抗癫痫药等)和剂型类型(口服药) 、肠外、局部用药等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 166    |    Report Code: BMIRE00026057    |    Category: Life Sciences

South & Central America Branded Generics Market

 南部和南部地区的品牌仿制药市场中美洲预计将从 2022 年的 243.3 亿美元增长到 2028 年的 432.8 亿美元;预计 2022 年至 2028 年复合年增长率为 10.1%。

 

南方品牌仿制药市场增长&中美洲的原因在于人口老龄化、诊断市场蓬勃发展以及医疗行业主要参与者不断增加的举措。此外,慢性病患病率的上升需要负担得起的治疗方案,预计在预测期内将为该地区的市场提供机会。按国家/地区划分,南美其他地区的市场中美洲分为智利、哥伦比亚、秘鲁、古巴、委内瑞拉和玻利维亚。这些国家正在大力投资改善医疗保健服务,重点关注初级和高级护理。根据世界银行的数据,2020年智利约12%的人口年龄在65岁以上。随着老年人口的增加,糖尿病、癌症和心血管疾病的患病率也在上升,同时推动南美其他地区制药和医疗保健行业的发展中美洲。因此,这些国家医疗机构数量的预期增加和老年人口的增加可能为未来几年品牌仿制药市场参与者的增长提供重大机会。

 

通过引入新功能和技术,欧洲品牌仿制药市场的供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动市场实现良好的复合年增长率。

 

outh &中美洲品牌仿制药

到 2028 年的市场收入和预测(十亿美元)

 

 

 

南  ;中美洲品牌仿制药市场细分

 

南美洲和南美洲中美洲品牌仿制药市场分为治疗应用、分销渠道、药物类别、配方类型和国家。 South&的治疗应用部分中美洲品牌仿制药市场细分为肿瘤、心血管疾病、糖尿病、神经病学、胃肠道疾病、皮肤病、镇痛和抗炎药。 2022 年,按治疗应用划分,其他细分市场占据最大市场份额。南部和南部中美洲品牌仿制药市场,按分销渠道划分为医院药房、零售药房、网上药房和药店。到 2022 年,零售药店领域可能会占据最大的市场份额。中美洲品牌仿制药市场按药物类别分为烷化剂、抗代谢药、激素、抗高血压、降脂药、抗抑郁药、抗精神病药、抗癫痫药等。到 2022 年,其他细分市场可能会占据最大的市场份额。中美洲品牌仿制药市场根据剂型类型分为口服、肠胃外、外用等。 2022 年,按配方类型划分,口服细分市场占据最大市场份额。基于国家、南部和地区中美洲品牌仿制药市场分为巴西、阿根廷和南美其他地区。中美洲。巴西在 2022 年占据最大的市场份额。

 

Aspen Holdings、阿斯利康、Bausch Health(Valeant Pharmaceuticals)、Dr. Reddy\'s Laboratories Inc. 、葛兰素史克公司、Hetero、Lupin、Mylan NV、Par Pharmaceuticals、Sandoz International Gmbh、赛诺菲和 Teva Pharmaceutical Industries Ltd. 是该地区品牌仿制药市场的领先公司。   



South & Central America Branded Generics Strategic Insights

Strategic insights for South & Central America Branded Generics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-branded-generics-market-strategic-framework.webp
Get more information on this report

South & Central America Branded Generics Report Scope

Report Attribute Details
Market size in 2022 US$ 24.33 Billion
Market Size by 2028 US$ 43.28 Billion
Global CAGR (2022 - 2028) 10.1%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 治疗应用
  • 肿瘤科
  • 心血管疾病
  • 糖尿病
  • 神经内科
  • 胃肠道疾病
  • 皮肤病
  • 镇痛消炎
By 分销渠道
  • 医院
  • 零售药店
  • 网上药店
  • 药店
By 药物类别
  • 烷化剂
  • 抗代谢药
  • 激素
  • 抗高血压药
  • 降脂药
  • 抗抑郁药
  • 抗精神病药
  • 抗癫痫药
By 剂型类型
  • 口服
  • 肠胃外
  • 外用
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Get more information on this report

    South & Central America Branded Generics Regional Insights

    The regional scope of South & Central America Branded Generics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-branded-generics-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Branded Generics Market

    1. Aspen Holdings
    2. AstraZeneca
    3. Bausch Health (Valeant Pharmaceuticals)
    4. Dr. Reddy's Laboratories Inc.
    5. GlaxoSmithKline plc
    6. Hetero
    7. Lupin
    8. Mylan N.V.
    9. Par Pharmaceuticals
    10. Sandoz International Gmbh
    11. Sanofi
    12. Teva Pharmaceutical Industries Ltd. 
    Frequently Asked Questions
    How big is the South & Central America Branded Generics Market?

    The South & Central America Branded Generics Market is valued at US$ 24.33 Billion in 2022, it is projected to reach US$ 43.28 Billion by 2028.

    What is the CAGR for South & Central America Branded Generics Market by (2022 - 2028)?

    As per our report South & Central America Branded Generics Market, the market size is valued at US$ 24.33 Billion in 2022, projecting it to reach US$ 43.28 Billion by 2028. This translates to a CAGR of approximately 10.1% during the forecast period.

    What segments are covered in this report?

    The South & Central America Branded Generics Market report typically cover these key segments-

  • 治疗应用 (肿瘤科, 心血管疾病, 糖尿病, 神经内科, 胃肠道疾病, 皮肤病, 镇痛消炎)
  • 分销渠道 (医院, 零售药店, 网上药店, 药店)
  • 药物类别 (烷化剂, 抗代谢药, 激素, 抗高血压药, 降脂药, 抗抑郁药, 抗精神病药, 抗癫痫药)
  • What is the historic period, base year, and forecast period taken for South & Central America Branded Generics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Branded Generics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South & Central America Branded Generics Market?

    The South & Central America Branded Generics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Aspen Holdings
  • AstraZeneca
  • Bausch Health (Valeant Pharmaceuticals)
  • Dr. Reddys Laboratories Inc.
  • GlaxoSmithKline plc
  • Hetero
  • Lupin
  • Mylan N.V.
  • Par Pharmaceuticals
  • Sandoz International Gmbh
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Who should buy this report?

    The South & Central America Branded Generics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Branded Generics Market value chain can benefit from the information contained in a comprehensive market report.